Haider Al-Saedi

Haider Al-Saedi

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 2023 in Emergent Materials
Verified
Journal Article
Open access
PDF file
HAHaider Al-Saedi
Haider Al-Saedi
RPRamyakrishna Pothu
Ramyakrishna Pothu
RBRajender Boddula
Rajender Boddula
MDMangesh A. Desai
Mangesh A. Desai
NANoora Al-Qahtani
Noora Al-Qahtani
Herein, we report the utilization of nitrogen and sulfur dual heteroatoms co-doped activated carbon (NSAC) by hydrothermal method for electrochemical supercapacitors. Various NSACs were made by using a fixed amount of activated carbon and changing the amounts of thioacetamide. From NSAC electrodes, the coin cell configuration was fabricated and the overall electrochemical conduct was evaluated by using cyclic voltammetry, galvanostatic charge-discharge, cycle life, and electrochemical impedance methodologies. The outcomes manifest that co-doping sulfur and nitrogen into the AC improves the electrochemical performance. In comparison to pure activated carbon, the optimized NSAC produced a higher specific capacitance value of 417 F g−1 at 0.7 A g−1 and also demonstrated outstanding charge-discharge cycling stability at 7 mA (5 A g−1), maintaining 76% of its opening capacitance after 60,000 cycles in the CR2032 device configuration. The impedance studies phase angle value of 85° has added evidence of the NSAC’s good capacitor performance. Thus, we believe this work is suitable for practical applications for energy storage devices. Graphical abstract

15 April 2019 in International Journal of Research in Pharmaceutical Sciences
Verified
Journal Article
Open access
PDF file
HAHaider F. Alsaedi
Haider F. Alsaedi
HAHaider Al-Saedi
Haider Al-Saedi
AAAdeeb Ahmed Kadhim Al-Zubaidy
Adeeb Ahmed Kadhim Al-Zubaidy
MRMukhallad Abdul Kareem Ramadhan
Mukhallad Abdul Kareem Ramadhan
HMHussein Abdelamir Mohammad
Hussein Abdelamir Mohammad
Imiquimod-induced psoriasis is an animal model of psoriasis. The antidiabetic metformin had anti-inflammatory, immunomodulation, antiangiogenesis and antiproliferative effect. The objective of this study was to evaluate the possible beneficial effect of metformin gel against imiquimod-induced psoriasis-like form by scoring the erythema and scaling besides measuring of tissue homogenate levels of IL17/IL23. Swiss albino mice were used in this experiment imiquimod 5% cream applied on shaved back of mice for six days, and this is an induction group and compared with a negative control group that involved mice treated with ointment base only for six days. Third group; metformin 10% gel applied on the back of mice with imiquimod for six days. The fourth group included used of metformin 15% gel with imiquimod for six days. This data was analysed for significant level when p ≥ 0.05 by using either ANOVA test for biochemical parameters levels evaluation. Furthermore, imiquimod 5% cream of induction group caused an elevation of inflammatory parameters; IL17 and IL23 in skin tissue homogenate when being compared to IL17 and IL23 level of the control group. Whereas, metformin 10% gels showed levels of IL17 and IL23 with significant different from induction group. In addition, metformin 15% gels exerted a significantly low level of IL17 and IL23. The possible considerable antipsoriatic activity of topical metformin gel through reducing scaling and erythema and mediated through modest anti-inflammatory effects by suppressing levels of IL17/23.

5 December 2025 in Materials Research Express
Verified
Journal Article
Open access
CGChintada Gopi
Chintada Gopi
HAHaider Al-Saedi
Haider Al-Saedi
KDKavyasri D
Kavyasri D
BAB V S Apparao
B V S Apparao
NPN K Prasasnna
N K Prasasnna
KBKishore Babu Bonigi
Kishore Babu Bonigi
A supercapacitor cell in organic electrolyte with carbon-based electrodes has been commercialized. However, there are a few supercapacitor cell systems on the market that use aqueous electrolytes. In the current study, a high-performance supercapacitor cell is constructed in an asymmetric configuration using hydrothermally manufactured Mn2O3 microspheres as a positive electrode and hydrothermally synthesized rGO-TiO2 as a negative electrode in an aqueous electrolyte. The device provides a wide operational voltage window of 0 to 1.6 V, significantly surpassing the voltage ranges typically seen in aqueous-based supercapacitors. It achieves exceptional electrochemical performance metrics, including a high specific capacitance of 321 F g⁻¹, an energy density of 114 W h kg⁻¹ and a power density of 571 W kg⁻¹. These results show a significant improvement over symmetric designs like Mn₂O₃//Mn₂O₃ (energy density: 37 W h kg⁻¹ at 357 W kg⁻¹) and rGO-TiO₂//rGO-TiO₂ (energy density: 18 W h kg⁻¹ at 214 W kg⁻¹). The asymmetric cell has an energy density of 71 W h kg⁻¹ and an ultra-high power density of 57,142 W kg⁻¹, making it suitable for rapid energy delivery applications. Additionally, excellent stability during cycling is observed at a higher discharge current density of 10.71 A g-1, sustaining more than 82% of the initial capacitance after 10,000 charge-discharge cycles. The adoption of a CR2032 coin cell type emphasizes the practicality of this high-voltage aqueous supercapacitor device for next-generation energy management and storage applications

31 October 2022
Verified
Journal Article
Closed access
HAHaider Al-Saedi
Haider Al-Saedi
MAM. R Al-Notazy
M. R Al-Notazy
MRM. A Ramadhan
M. A Ramadhan
WAW Khaled Younis Albahadly
W Khaled Younis Albahadly

10 August 2026 in Cells
Verified
Journal Article
Open access
PDF file
WAWaleed Khaled Younis Albahadly
Waleed Khaled Younis Albahadly
MRMohammed Rasool
Mohammed Rasool
HAHaider Al-Saedi
Haider Al-Saedi
ZAZahraa Abed Al-Kareem
Zahraa Abed Al-Kareem
SHSamer Ali Hasan
Samer Ali Hasan
MAMeeqaat H. Altrufi
Meeqaat H. Altrufi
Background: Cisplatin is a widely used chemotherapeutic agent whose clinical application is often limited by severe hepatorenal toxicity associated with oxidative stress and cellular injury. Nicotinamide riboside (NR), a natural precursor of nicotinamide adenine dinucleotide (NAD+), has emerged as a promising cytoprotective compound with antioxidant and metabolic regulatory properties. This study investigated the protective effects of NR against cisplatin-induced hepatorenal toxicity and explored its potential mechanisms of action. Methods: Thirty-six adult male Wistar rats were randomly assigned to four groups (n = 6): control, cisplatin (7 mg/kg, i.p.), nicotinamide riboside (50 mg/kg/day, orally), and cisplatin plus NR. Renal and hepatic function biomarkers, lipid profile parameters, oxidative stress markers, and antioxidant status were evaluated. Relative mRNA expression of Nrf2 and NQO1 was determined using RT-qPCR. Histopathological examinations of liver and kidney tissues were also performed. Results: Cisplatin administration induced marked hepatorenal injury, evidenced by significant elevations in serum KIM-1 (395.27 vs. 116.04 ng/mL), urea (71.16 vs. 21.33 mg/dL), creatinine (3.49 vs. 0.26 mg/dL), AST (325.83 vs. 95.16 U/L), and ALT (102.83 vs. 45.50 U/L), accompanied by dyslipidemia, oxidative stress, and severe histopathological alterations. NR treatment significantly attenuated these changes, reducing KIM-1, urea, creatinine, AST, and ALT by 55.5%, 47.8%, 48.1%, 55.4%, and 33.5%, respectively, compared with the cisplatin group. NR also improved antioxidant status by increasing GSH and SOD levels while reducing MDA and NO concentrations. Hepatic NAD+ levels and the NAD+/NADH ratio were significantly decreased by cisplatin and significantly restored by NR treatment. In addition, NR significantly upregulated the relative mRNA expression of Nrf2 and NQO1 and markedly preserved hepatic and renal histological architecture. Pharmacological inhibition of Nrf2 with ML385 significantly attenuated these protective effects of NR across biochemical, lipid, and oxidative stress parameters, confirming that they are, at least in part, Nrf2-dependent. Conclusions: Nicotinamide riboside exerts protective effects against cisplatin-induced hepatorenal toxicity that are mechanistically linked to activation of the Nrf2/NQO1 antioxidant pathway and restoration of hepatic NAD+ homeostasis. This finding supports the potential of NR as an adjunctive strategy for mitigating cisplatin-associated hepatorenal injury and warrants further preclinical and clinical investigation.

3 April 2026 in Molecules
Verified
Journal Article
Open access
PDF file
WAWaleed Khaled Younis Albahadly
Waleed Khaled Younis Albahadly
HAHaider Al-Saedi
Haider Al-Saedi
JAJamal Ali Ashoor
Jamal Ali Ashoor
MRMohammed Rasool
Mohammed Rasool
SHSamer Ali Hasan
Samer Ali Hasan
MAMeeqaat H. Altrufi
Meeqaat H. Altrufi
Psoriasis is a chronic immune-mediated inflammatory skin disorder characterized by excessive keratinocyte proliferation, oxidative stress, and dysregulated cytokine signaling. Although topical corticosteroids remain the first-line therapy, their long-term use is often limited by adverse effects, highlighting the need for safer non-steroidal therapeutic alternatives. This study investigated the therapeutic efficacy and underlying mechanisms of a topical astaxanthin (AST) formulation in an imiquimod (IMQ)-induced mouse model of psoriasiform dermatitis. Following IMQ induction, mice were randomly assigned to vehicle, clobetasol, or AST treatment groups (0.5–1.5%) for 14 days. Disease progression was evaluated through biochemical analysis of oxidative stress biomarkers, including NADPH oxidase (NOX), malondialdehyde (MDA), nitric oxide (NO), and superoxide dismutase (SOD), as well as ELISA-based quantification of inflammatory cytokines (TNF-α, IL-6, IL-17, and IL-23). Histopathological changes were assessed using hematoxylin and eosin staining, while molecular alterations were examined by RT-qPCR analysis of psoriasis-associated keratin genes (Krt16, Krt17, and Krt6a) and evaluation of JAK–STAT signaling activity. AST treatment significantly suppressed the IL-23/IL-17 inflammatory axis, reduced NOX activity and lipid peroxidation, restored endogenous antioxidant defenses, and inhibited JAK–STAT signaling. These biochemical and molecular effects were accompanied by marked downregulation of keratin gene expression and substantial histological improvement, including normalization of epidermal thickness, reduced parakeratosis, and decreased inflammatory infiltration. Notably, high-dose AST demonstrated therapeutic efficacy comparable to, and in some parameters exceeding, that of clobetasol. Collectively, these findings indicate that topical astaxanthin exerts coordinated antioxidant, anti-inflammatory, and anti-proliferative effects, supporting its potential as a promising multi-target non-steroidal therapeutic candidate for psoriasis management.